Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Bettersyn Biotech is a prominent Chinese life sciences service provider focused on the distribution and production of laboratory consumables, reagents, and analytical instruments. The company operates a dual business model, acting as a high-level agent for international brands such as Corning, Takara, and Merck, while also expanding its proprietary Labselect brand. Its comprehensive product range supports diverse research fields including molecular biology, cell culture, and biopharmaceutical development. With a robust supply chain and technical support network, Bettersyn serves thousands of customers across academic institutions, hospitals, and biotech enterprises in China. The company is headquartered in Shanghai and maintains a significant presence across major Chinese research hubs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Bettersyn Biotech.